Stoke Therapeutics Appoints Eric Olson, MS, MBA as Chief Business Officer
September 4, 2024
– Mr. Olson brings two decades of successful corporate business development experience with an emphasis on rare diseases and ...Stoke Therapeutics to Present at Upcoming Investor Conferences in September
September 3, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Sep. 3, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated t ...Stoke Therapeutics to Present Encore Data at the 15th European Epilepsy Congress that Demonstrate the Potential for ...
September 3, 2024
– First presentation of landmark data from Phase 1/2a and OLE studies of zorevunersen that showed substantial reductions in s ...Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
August 16, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Aug. 16, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated ...Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
August 7, 2024
– FDA removes Partial Clinical Hold as company advances toward a Phase 3 registrational study of zorevunersen (STK-001) in ch ...Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
July 16, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Jul. 16, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated ...Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
June 18, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Jun. 18, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated ...Stoke Therapeutics to Present at Upcoming Investor Conferences in June
June 3, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--Jun. 3, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated t ...Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
May 17, 2024
BEDFORD, Mass. --(BUSINESS WIRE)--May 17, 2024-- Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated t ...Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates
May 6, 2024
– Recent data demonstrating reductions in seizure frequency and improvements in cognition and behavior support the potential ...